Pathogens最新文献

Plesiomonas shigelloides, an aquatic Gram-negative bacillus often associated with self-limiting gastroenteritis, has been reported worldwide. However, to date, no reviews have specifically investigated P. shigelloides bacteremia, which is rare and potentially fatal. This scoping review aimed to examine the existing literature to identify the epidemiology, clinical characteristics, antimicrobial susceptibility, and outcomes of P. shigelloides bacteremia. A PRISMA-ScR-guided search of PubMed, Scopus, Web of Science, and Embase identified 22 published cases, all reported as single-patient case reports. Cases were globally distributed, with the majority reported from the Americas and Europe. The median patient age was 46 years. The case fatality rate was 27.3% (n = 6/22). Most patients had identifiable host risk factors, particularly hematological disorders, neonatal status, or immunocompromised status, and environmental exposure such as raw seafood consumption or contact with freshwater. Clinical presentations were heterogeneous, commonly including fever and sepsis or septic shock. Microbiologically, P. shigelloides demonstrated consistent intrinsic resistance to ampicillin while retaining susceptibility to multiple antimicrobial classes. Poor outcomes were more closely associated with host factors and delayed presentation than with antimicrobial resistance. Early diagnosis, targeted therapy, and antimicrobial stewardship are essential for optimizing outcomes in this rare but severe infection.

Leishmania guyanensis is one of 15 American human-pathogenic species, frequently linked to therapeutic failure due to its marked genetic plasticity and adaptability under drug pressure. To broaden the genomic understanding of this species, its biological traits, and potential therapeutic alternatives, we sequenced the L. guyanensis strain MHOM/BR/75/M4147. Raw reads underwent quality-filtering and assembly. Taxonomic classification utilized BLASTn and Kraken2, confirming that 99.95% of contigs matched Leishmania. The assembled genome size was 31 Mb, with an N50 of 4743 bp and 40.85× coverage. Variant calling subsequently identified 36,665 SNPs, 8210 indels, and chromosomal aneuploidies. Genomic annotation identified 3119 proteins with known molecular functions in L. guyanensis, alongside 6371 orthologous genes shared with L. major and L. panamensis. The search for pharmacological relevance yielded ten candidate genes, including one calpain and nine GSK3 family members. Phylogenetic reconstruction using the polA1 gene consistently grouped L. guyanensis, demonstrating strong discriminatory capacity, with L. martiniquensis emerging as the most divergent species. Overall, these findings expand the available genomic framework for L. guyanensis and support advances in species-specific diagnostic approaches.

This study aimed to classify Escherichia coli phages using bioinformatics analysis systematically and to establish corresponding PCR and qPCR detection methods for rapid molecular typing and identification. Based on 419 complete E. coli phage genomes available in NCBI, phylogenetic and pan-genomic analyses were conducted to classify the phages at the family, subfamily, and genus levels and to identify highly conserved core genes. Specific primers targeting these core genes were designed, and their specificity, sensitivity, and reproducibility were verified using conventional PCR and dye-based qPCR. A total of 357 phages were successfully classified, encompassing 10 families, 20 subfamilies, and 67 genera. Pan-genomic analysis identified type-specific core genes within 16 taxa, including Ackermannviridae and Demerecviridae, for which 16 pairs of primers were designed. Validation using bacteriophages isolated from Xinjiang cattle farms showed distinct single PCR bands with high specificity, and the qPCR assay achieved a sensitivity of up to 10^-5 µg/µL. This study established an efficient and broad-spectrum molecular typing and detection method for E. coli phages, providing a powerful preliminary screening tool for phage selection.

Interferon-stimulated gene 15 (ISG15) is an interferon-induced ubiquitin-like protein that plays an important role in antiviral defense and inflammatory responses, primarily through the process of ISGylation, whereby ISG15 is covalently conjugated to target proteins. Beyond its intracellular functions, a portion of free unconjugated ISG15 is also released into the extracellular environment during infections and diseases such as cancer. Extracellular ISG15 is known to regulate immune cell activity and cytokine production. Despite its immune-modulatory role, how ISG15 is released from cells has remained unclear. In this study, we have identified a non-lytic mechanism by which human macrophages release ISG15. Using lipopolysaccharide (LPS) as a stimulus, we show that extracellular LPS triggers unconjugated ISG15 release by utilizing plasma membrane-localized Gasdermin D (GSDMD) pores. Mechanistically, LPS via the autocrine/paracrine action of type-I interferon (IFN) activates caspase-4 (Casp4) to cleave the N-terminal domain of GSDMD for the formation of cell surface GSDMD pores that permit the extracellular release of unconjugated ISG15 in the absence of lytic cell death. Together, our studies have identified the IFN-Casp4-GSDMD axis as a previously unrecognized non-classical pathway for unconjugated ISG15 release from cells.

Oropouche virus (OROV) has emerged as a significant arboviral pathogen in South America, responsible for recurrent outbreaks of febrile illness. In the Loreto region of Peru, more than 600 cases were reported in 2024, markedly exceeding expected incidence rates. We conducted a retrospective observational study using clinical-epidemiological records of all RT-qPCR-confirmed cases of Oropouche fever from the Regional Health Directorate of Loreto between October 2024 and March 2025. A total of 100 confirmed cases were identified. The most frequent symptoms were fever (88%), headache (78%), and myalgia (72%). No atypical or neurological presentations were reported. No severe cases or deaths occurred. Eight patients required hospitalization, mainly due to severe abdominal pain, persistent vomiting, arthralgia, and pregnancy. Six pregnant women were identified; three experienced pregnancy complications, though no fetal malformations or miscarriages were observed. This outbreak represents a new OROV epidemic in the region, with fewer cases than in 2024 and predominantly mild clinical courses. Although outcomes were generally favorable, the occurrence of complications in pregnant women underscores the importance of continued molecular surveillance and targeted public health interventions.

African Swine Fever is a lethal hemorrhagic disease caused by a DNA virus that affects domestic and wild pigs, causing serious economic losses in the swine industry. African Swine Fever virus (ASFV) is maintained in a sylvatic cycle that includes wildlife and Ornithodoros tick species. A huge investigation about ASFV structure and its infection process in pigs has been carried out in recent years, and although these studies have increased our knowledge about its pathogenesis, there are still many unclear aspects about which immune responses protect swine hosts against the disease caused by this virus. The mechanisms of ASFV infection in ticks are even less well understood. This infection is long term and persistent, with relatively high levels of virus replication in different tick tissues. According to specific infected tissues, the Ornithodoros tick species that are ASFV-competent vectors show transstadial, transovarial and/or venereal transmissions. This review is focused on the main process taking place at the virus-vector interface, summarizing the latest findings about the molecular and cellular aspects of ASFV infection in ticks, which could constitute the basis for developing novel strategies to interrupt the arthropod transmission cycle.

The frequent and indiscriminate use of all classes of synthetic anthelmintics to deworm small ruminants has decreased their effectiveness in a worldwide problem of anthelmintic resistance. Using active plant metabolites with anthelmintic properties has become a suggested alternative to control parasitic helminths. The present study investigated the ovicidal and larvicidal activity of a fraction (CnF4) containing protocatechuic acid (3,4-dihydroxybenzoic acid) from Chamaecrista nictitans (Fabaceae) and a commercial standard of protocatechuic acid against strains of the parasitic nematode Haemonchus contortus susceptible (HcIVM-S) and resistant (HcIVM-R) to ivermectin, using egg hatch inhibition (EHI) and L3 larval mortality assays. The CnF4 fraction showed an EHI greater than 90% at 0.8 mg/mL against HcIVM-S and an EHI = 88.39% at 1.6 mg/mL against HcIVM-R. The commercial standard of protocatechuic acid displayed an EHI of 97.49% at 0.25 mg/mL against HcIVM-S and an EHI greater than 98% at 0.5 mg/mL. In the larval mortality assays, protocatechuic acid caused 72.4% larval mortality of HcIVM-S at 8 mg/mL and 53.2% mortality of HcIVM-R at 16 mg/mL. These results indicate that protocatechuic acid was more effective in inhibiting egg hatching and causing larval mortality against HcIVM-S compared to HcIVM-R.

Biofilms formed by Staphylococcus aureus on medical devices and tissue surfaces are a major contributor to persistent infections due to their resistance to antibiotics. Hydrodynamic forces in physiological and device-associated environments significantly influence biofilm development, yet the dynamics of detachment and regrowth under flow remain poorly quantified. In this study, biofilm surface coverage was measured in microfluidic flow assays across combinations of shear rates and nutrient concentrations. A computational workflow was used to segment biofilm trajectories into three kinetic phases-growth, exodus, and regrowth-based on surface coverage dynamics. Each phase was modeled using parametric functions, and fitted parameters were interpolated across experimental conditions to reconstruct biofilm lifecycles throughout the flow-nutrient conditions. The analysis revealed that intermediate shear rates triggered early detachment events while suppressing subsequent regrowth, whereas lower and higher shear regimes favored biofilm persistence. The resulting model enables quantitative comparison of condition-specific biofilm behaviors and identifies key thresholds in mechanical and nutritional inputs that modulate biofilm stability. These findings establish a phase-resolved framework for studying S. aureus biofilms under hydrodynamic stress and support future development of targeted strategies to control biofilm progression in clinical and engineered systems.

Methicillin-resistant coagulase-negative staphylococci (MRCoNS) are a major cause of infectious diseases, owing to their ability to form biofilms and colonize community and hospital environments. MRCoNS strains were identified using biochemical tests, an MALDI-TOF MS analyzer, and PCR-based 16S rRNA gene confirmation. This study was designed to assess antibiotic resistance and biofilm-forming capacity and to determine the presence of the mecA, mecC, agrA, srtA, icaABCD, bap, fnbAB, and clfAB genes in MRCoNS isolates. From patients undergoing random screening during hospitalization in the Orthopedics Clinic in Slovakia, 28 strains of MRCoNS were identified: S. epidermidis (n = 10), S. hominis (n = 8), S. haemolyticus (n = 4), S. lugdunensis (n = 3), while S. simulans, S. pasteuri, and S. warneri were detected only once. The highest rates of resistance were observed for ampicillin, oxacillin, rifampicin, trimethoprim (100%), and erythromycin (62%). The mecA gene was detected in 12 analyzed isolates. In 12 isolates, MDR, strong efflux pump activity, and strong or moderate biofilm formation were simultaneously detected. Our findings highlight the problems posed by biofilm-forming, resistant CoNS in hospitalized patients and the importance of diagnostics, separation, rapid treatment, and proper hospital hygiene.

The incidence of tuberculosis disease (TBD) in New Brunswick (NB) is low but has been rising over the past decade. Analyzing these trends can help identify specific risk factors and transmission patterns to guide targeted public health strategies. This study aimed to provide a comprehensive and detailed characterization of TBD in NB by examining data from 1 January 2002, to 31 December 2024. All TB patients with Mycobacterium tuberculosis complex (MTBC) clinical isolates identified in NB healthcare facilities were eligible for inclusion in the study. We analyzed demographic, drug susceptibility, and 24-locus Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU-VNTR) data from 166 patients. Most MTBC isolates were pan-susceptible to first-line anti-tuberculosis drugs (90.9-98.1%), with 2.4% showing multidrug resistance. The MIRU-VNTR demonstrated a high discriminatory power of 0.9982 and a low clustering rate of 20.4%. Two samples from the same patient, collected seven years apart, showed different genetic profiles, suggesting that the second episode was a new infection. The most prevalent MTBC lineage was East African Indian (n = 23, 13%). This study provides early insights into TB trends in NB, including what may be the first recorded case of TB reinfection in NB. Our findings will help guide future TB research, policies, and public health interventions in the region.